Eli Lilly and Co
(MEX:LLY)
MXN
16199
-98.2 (-0.6%)
Market Cap: 15.75 Til
Enterprise Value: 16.20 Til
PE Ratio: 132.31
PB Ratio: 65.52
GF Score: 69/100 - Q1 2024 Eli Lilly and Co Earnings Call TranscriptApr 30, 2024MXN13339 (+6.97%)Earnings
- Q4 2023 Eli Lilly and Co Earnings Call TranscriptFeb 06, 2024MXN11999 (+4.25%)Earnings
- Eli Lilly and Co at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Eli Lilly and Co at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Eli Lilly and Co at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Eli Lilly and Co Earnings Call TranscriptNov 02, 2023MXN10000Earnings
- Eli Lilly and Co at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Eli Lilly and Co Earnings Call TranscriptAug 08, 2023MXN8904 (+15.17%)Earnings
- Eli Lilly and Co to Provide Alzheimer's Disease Update TranscriptJul 17, 2023
- Eli Lilly and Co at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Eli Lilly and Co at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Eli Lilly and Co Earnings Call TranscriptApr 27, 2023MXN7000 (+3.63%)Earnings
- Eli Lilly and Co at Cowen Health Care Conference TranscriptMar 06, 2023
- Eli Lilly and Co at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Eli Lilly and Co at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q4 2022 Eli Lilly and Co Earnings Call TranscriptFeb 02, 2023MXN6172 (-4.01%)Earnings
- Eli Lilly and Co at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Eli Lilly and Co Guidance Call 2023 TranscriptDec 13, 2022
- Eli Lilly and Co at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Q3 2022 Eli Lilly and Co Earnings Call TranscriptNov 01, 2022MXN6870 (-4.08%)Earnings
- Eli Lilly and Co at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Eli Lilly and Co at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 Eli Lilly and Co Earnings Call TranscriptAug 04, 2022MXN6203.6 (-3.48%)Earnings
- Eli Lilly and Co at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Eli Lilly and Co Diabetes & Obesity Update at ADA Call TranscriptJun 07, 2022
- Eli Lilly and Co at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Eli Lilly and Co at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Eli Lilly and Co Earnings Call TranscriptApr 28, 2022MXN6129 (+5.31%)Earnings
- Eli Lilly and Co at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Eli Lilly and Co at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Eli Lilly and Co at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Q4 2021 Eli Lilly and Co Earnings Call TranscriptFeb 03, 2022MXN5044.09 (-2.48%)Earnings
- Eli Lilly and Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Eli Lilly and Co Investment Community Meeting TranscriptDec 15, 2021
- Eli Lilly and Co at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Eli Lilly and Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2021
- Eli Lilly and Co at Sanford C Bernstein Operational Decisions Conference TranscriptNov 04, 2021
- Q3 2021 Eli Lilly and Co Earnings Call TranscriptOct 26, 2021MXN5003 (+0.81%)Earnings
- Eli Lilly and Co at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 28, 2021
- Eli Lilly and Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Eli Lilly and Co at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Eli Lilly and Co Earnings Call TranscriptAug 03, 2021MXN4881.15Earnings
- Eli Lilly and Co to Discuss Diabetes Portfolio Update at ADA Call TranscriptJul 01, 2021
- Eli Lilly and Co at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 18, 2021
- Eli Lilly and Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Eli Lilly and Co at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Eli Lilly and Co at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Eli Lilly and Co ESG Sustainability Call TranscriptMay 04, 2021
- Q1 2021 Eli Lilly and Co Earnings Call TranscriptApr 27, 2021MXN3670 (-1.59%)Earnings
- Eli Lilly and Co Alzheimer's Update at AD/PD TranscriptMar 15, 2021
- Eli Lilly and Co at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Eli Lilly and Co at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Eli Lilly and Co at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- Eli Lilly and Co at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 12, 2021
- Q4 2020 Eli Lilly and Co Earnings Call TranscriptJan 29, 2021MXN4200 (-0.12%)Earnings
- Eli Lilly and Co Update on SARS-CoV-2 Neutralizing Antibody Program - Conference Call TranscriptJan 26, 2021
- Eli Lilly and Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Eli Lilly and Co 2021 Guidance Call TranscriptDec 15, 2020
- Eli Lilly and Co at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2020
- Eli Lilly and Co to Provide an Overview of Tirzepatide Phase 3 Clinical Program - Conference Call TranscriptNov 20, 2020
- Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference Call TranscriptNov 20, 2020
- Eli Lilly and Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- Eli Lilly and Co at Sanford C Bernstein Operational Decisions Conference (Virtual) TranscriptNov 16, 2020
- Q3 2020 Eli Lilly and Co Earnings Call TranscriptOct 27, 2020MXN2777 (-7.83%)Earnings
- Eli Lilly and Co at HMG Live Houston CIO Executive Leadership Summit TranscriptOct 20, 2020
- Eli Lilly and Co to Provide Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs - Conference Call TranscriptOct 07, 2020
- Eli Lilly and Co to Discuss ESMO 2020 Presentations - Conference Call TranscriptSep 21, 2020
- Eli Lilly and Co at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Eli Lilly and Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Eli Lilly and Co Earnings Call TranscriptJul 30, 2020MXN3360.7 (-6.10%)Earnings
- Eli Lilly and Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Eli Lilly and Co at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Eli Lilly and Co at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Eli Lilly and Co Annual Shareholders Meeting TranscriptMay 04, 2020
- Q1 2020 Eli Lilly and Co Earnings Call TranscriptApr 23, 2020MXN3939 (+1.78%)Earnings
- Eli Lilly and Co at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Eli Lilly and Co at Cowen HealthCare Conference TranscriptMar 03, 2020
- Eli Lilly and Co at Leerink Global Healthcare Conference TranscriptFeb 27, 2020
- Eli Lilly and Co at Guggenheim Healthcare Talks Idea Forum and Oncology Day TranscriptFeb 13, 2020
- Q4 2019 Eli Lilly and Co Earnings Call TranscriptJan 30, 2020MXN2686.9 (+2.05%)Earnings
- Eli Lilly and Co at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Eli Lilly and Co 2020 Financial Guidance Call TranscriptDec 17, 2019
- Eli Lilly and Co at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Eli Lilly and Co at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Eli Lilly and Co Earnings Call TranscriptOct 23, 2019MXN2050 (-1.56%)Earnings
- Eli Lilly and Co to Discuss ESMO 2019 Presentations - Conference Call TranscriptOct 02, 2019
- Eli Lilly and Co at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Eli Lilly and Co to Discuss World Conference on Lung Cancer Presentation TranscriptSep 09, 2019
- Q2 2019 Eli Lilly and Co Earnings Call TranscriptJul 30, 2019MXN2050Earnings
- Eli Lilly and Co at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Eli Lilly and Co to Discuss ADA Presentations and Diabetes Portfolio TranscriptJun 10, 2019
- Eli Lilly and Co at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Eli Lilly and Co at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Eli Lilly and Co Earnings Call TranscriptApr 30, 2019MXN2280Earnings
- Eli Lilly and Co at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Eli Lilly and Co at Cowen Health Care Conference TranscriptMar 11, 2019
- Eli Lilly and Co at Leerink Partners Global Healthcare Conference TranscriptFeb 27, 2019
- Eli Lilly and Co at Guggenheim Partners Oncology Day TranscriptFeb 14, 2019
- Q4 2018 Eli Lilly and Co Earnings Call TranscriptFeb 06, 2019MXN2307.04Earnings
Eli Lilly and Co at Guggenheim Healthcare Talks Oncology Day Transcript
Feb 09, 2023 / 03:10PM GMT
Release Date Price:
MXN6430
(-0.80%)
Seamus Christopher Fernandez
Guggenheim Securities, LLC, Research Division - Senior Analyst of Global Pharmaceuticals
All right. Thanks, everybody. I'm Seamus Fernandez, the global biopharma analyst here at Guggenheim Securities. This is our Fifth Annual Oncology Conference.
Really pleased to be joined by Eli Lilly. To my far left is Jake Van Naarden, CEO of Loxo Oncology at Lilly and President, Lilly Oncology; and Dr. David Hyman, immediately to my left here, is Chief Medical Officer of Lilly Oncology.
Questions & Answers
Seamus Christopher Fernandez
Guggenheim Securities, LLC, Research Division - Senior Analyst of Global Pharmaceuticals
So Jake, maybe just to kick us off, you can give us a little bit of a sense of key drivers. I think we were just talking about how impressive a quarter we just saw out of Verzenio, but maybe I'll leave it for you to take it away from there.
Jacob S. Van Naarden
Eli Lilly and Company - Senior VP, CEO of Loxo Oncology & President of Lilly Oncology
Yes,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)